29
Participants
Start Date
January 31, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
GCS-100
GCS-100 is a modified citrus pectin that binds to and sequesteres circulating galectin-3, a protein that has been shown to promote organ disease (fibrosis).
Renal Associates PA / Research Division, San Antonio
Denver Nephrologists, PC, Denver
Southwest Clinical Research Institute, Tempe
California Institue of Renal Research, La Mesa
Lead Sponsor
La Jolla Pharmaceutical Company
INDUSTRY